Clinical Trials Available at GCRI

All Solid Tumor Patients:

• A Phase I/II Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI4736 in Subjects With Advanced Solid Tumors

Breast Cancer:

• A Phase III Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients with HER2+ Metastatic Breast Cacner Who Have Received Two or More Prior HER2+ Directed Regimes in the Metastatic Setting (NALA)
• A Phase III Trial of Niraparib Versus Physician's Choice in HER2-ve, Germline BRCA Mutation Positive Breast Cancer Patients (BRAVO)

Pancreatic Cancer:

• A Phase II Study of BMP31510 Alone and in Combination with Gemcitabine in Subjects with Advanced or Metastatic Pancreatic Cancer